KMT2A/TXNRD1 gene fusion probe is used to detect a rare chromosomal rearrangement between the KMT2A(11q23.3) and TXNRD1(12q23.3) genes, and is typically identified in cases of B-lymphoblastic leukemia (B-ALL) and often detected via RNA sequencing before confirmation with dual-color, dual-fusion FISH.